Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

NSAIDs may not affect soft tissue healing but should be used carefully for bone fractures and more research is needed to understand sex differences in response.

Syphilis has a wide range of symptoms that can look like other diseases, and if not treated, it can progress to a more serious stage, especially in HIV-positive patients.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

The U.S. military's teledermatology program was effective in providing fast and successful skin care in remote locations, preventing unnecessary evacuations.

Thymic transplantation normalized some T-cells but not others, maintaining immune function.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Laser hair reduction near the eyebrows can cause serious eye injuries even with safety measures.

Skin problems can be linked to sexual abuse, requiring careful medical and psychological evaluation.

Cetuximab can cause eyelash growth, which is rare but manageable.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

ICL is a condition with low CD4+ T cells like AIDS but not caused by HIV, and normal CD4+ T cell counts may vary between men and women.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

COVID-19 can cause various skin problems, including reactions to protective gear and medication, with different rates reported worldwide, and more research is needed to fully understand these skin issues.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Toxic Epidermal Necrolysis is a rare, serious skin condition that can affect anyone, is more common in women, and may be linked to genetics, with a 20% mortality rate mainly due to sepsis.

The document concludes that veterinary dermatologists need more experience and a better approach to treating skin diseases in nonhuman primates.

Bimatoprost can cause longer, thicker, darker eyelashes and eyebrows.

The COVID-19 pandemic led to fewer dermatology visits and changed the types of skin conditions patients experienced.

Some diseases can improve the outcomes of other diseases, leading to new treatment possibilities.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Quick treatment of hair disorders in teenage girls is important because of the emotional effects.

Derma rollers show promise for skin improvement and drug delivery, but more research is needed on their safety and effectiveness.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

Tailor treatments for vitiligo to patient needs for best results.

High-potency steroids or tacrolimus are effective treatments for Erosive Pustular Dermatosis of the Scalp.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.